140 Genetic Clues Uncovered in Breakthrough Study on Age-Related Hearing Loss

140 Genetic Clues Uncovered in Breakthrough Study on Age-Related Hearing Loss

John Bailey
John Bailey•
• 2 Min.
A flowchart titled "Maternal Inheritance by Mitochondrial DNA" with boxes labeled male, female, and other inheritance types, connected by arrows showing the flow of genetic information.

140 Genetic Clues Uncovered in Breakthrough Study on Age-Related Hearing Loss

A large-scale genetic study has uncovered 140 genetic locations linked to age-related hearing loss. Published in Nature Communications in 2026, the research analysed diverse populations to reveal new insights into why hearing declines with age. The findings also highlight differences in genetic risk across ancestry groups.

The study used a multi-ancestry genome-wide association approach (GWAS) to pinpoint genetic factors behind age-related hearing loss (ARHL). By combining genomic data from varied populations, researchers identified 140 distinct loci tied to the condition. Many of these genetic markers sit near genes essential for cochlear hair cell function, synaptic communication, and ion channel regulation.

Further analysis integrated transcriptomic and epigenomic data, clarifying how these loci influence hearing loss at a molecular level. The results strengthened the synaptopathy hypothesis—the idea that synaptic damage in the inner ear plays a key role in ARHL. This suggests that protecting synapse health could be a future treatment focus.

The research also uncovered new biological pathways involved in ARHL, including mitochondrial function, oxidative stress responses, and inflammatory signalling. Evidence pointed to chronic low-grade inflammation as a contributor to progressive hearing decline. Additionally, mitochondrial genes were confirmed as critical for maintaining cochlear resilience, while redox imbalances increased cell vulnerability.

Using the data, scientists developed polygenic risk scores (PRS) to better predict an individual's likelihood of developing ARHL. These scores showed improved accuracy across different populations. However, no clinical trials or preclinical studies have yet explored therapies based on these genetic discoveries.

The study expands understanding of ARHL by linking genetic risks to cellular processes like inflammation, mitochondrial health, and synaptic function. While no treatments have emerged from these findings, the research provides a foundation for future studies. Improved polygenic risk scores may also help identify those most at risk of hearing loss as they age.

Neueste Nachrichten